8-K ·Filed May 7, 2026

PRVA

Privia Health Group, Inc.
MIXED
Impact 6/10
Horizondays Processed4mo ago SEC0001759655-26-000027
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The massive GAAP EPS miss vs consensus will pressure the stock near-term, but the strong revenue beat, 36% Adjusted EBITDA growth, and reaffirmed guidance suggest underlying business momentum. Watch for the conference call to understand the GAAP EPS miss drivers (likely stock-based comp and higher tax provision) and whether the Street focuses on adjusted metrics or GAAP disappointment.

DirectionMixed
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
PRVA ▼ -0.83% at T+60d
NEUTRAL call ✗ call lost -0.83% · α vs SPY -4.67% · entry $23.99 → $23.79
Entry anchored
May 7, 2026
via day open
T+1d
-3.88%
call -3.88% · α -4.71%
$23.06
settled 5mo ago
T+5d
-5.67%
call -5.67% · α -7.17%
$22.63
settled 5mo ago
T+20d
-13.88%
call -13.88% · α -17.02%
$20.66
settled 4mo ago
T+60d
-0.83%
call -0.83% · α -4.67%
$23.79
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Privia Health reported Q1 2026 revenue of $603.8M (+25.8% YoY) and GAAP EPS of $0.02, well below the $0.25 consensus estimate. Adjusted EBITDA grew 36.3% to $36.7M, and the company reiterated full-year 2026 guidance across all key metrics while raising its Attributed Lives outlook. The GAAP EPS miss is significant, but the strong revenue beat, robust operational metrics, and reaffirmed guidance provide a mixed picture.

Key Financial Metrics

EPS
$0.02
est $0.25 · -92.0%
Revenue
$603.8M
est $561.9M · +7.5% · +25.8% YoY
Rating
strong miss
Guidance
$2,350M-$2,450M
maintained
Free Cash Flow
-$49.5M
Gross Margin
20.8%

Key Facts

  • Q1 2026 revenue of $603.8M (+25.8% YoY) beat consensus of $561.9M
  • GAAP EPS of $0.02 missed consensus of $0.25 by 92%
  • Adjusted EBITDA of $36.7M, +36.3% YoY
  • Full-year 2026 guidance reiterated across all key metrics; Attributed Lives guidance raised to 1.60M-1.625M
  • Practice Collections of $914.8M, +14.6% YoY
  • Operating cash flow used $49.5M in Q1 vs $24.1M used in Q1 2025
  • Cash balance of $419.5M, down from $479.7M at year-end 2025

Financial Impact

Revenue beat by $41.9M (+7.5% vs consensus); GAAP EPS missed by $0.23 (-92% vs consensus); Adjusted EBITDA grew 36.3% YoY

revenueepsadjustedEbitdacashFlow

Risk Factors

  • GAAP EPS miss of 92% vs consensus could trigger significant sell-off
  • Operating cash flow negative $49.5M vs negative $24.1M a year ago, driven by large accounts receivable build
  • Cash balance declined $60.2M in the quarter
  • High stock-based compensation ($21.9M) continues to depress GAAP profitability

Market Snapshot

Exchange
Nasdaq
Sector
Services-Health Services
Analyst Consensus
89% bullish (27 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001759655-26-000027
Document: prva-20260507.htm0001759655-26-000027
Document: 0001759655-26-000027-index-headers.html0001759655-26-000027
Document: 0001759655-26-000027-index.html0001759655-26-000027
Document: 0001759655-26-000027.txt0001759655-26-000027
8-K Data (Synthetic)0001759655-26-000027
15 reports for PRVA
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+60▲ +10.73%Mar 9, 2026
Filters
Rows
Reports for PRVA — sortable, filterable
TypeNow
Jul 13, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$28.03 $21.98▼ −21.58%▼ −24.08%$20.30 (−27.58%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$27.77 $22.00▼ −20.78%▼ −23.02%$20.30 (−26.90%)
Jul 7, 2026
12w ago
Press Release
NEUTRAL ★ 2/10
$27.23 $23.79▼ −12.63%▼ −13.97%$20.30 (−25.45%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$27.23 $23.79▼ −12.63%▼ −13.97%$20.30 (−25.45%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$27.36 $23.86▼ −12.79%▼ −12.38%$20.30 (−25.80%)
May 27, 2026
18w ago
Press Release
NEUTRAL ★ 4/10
$21.74 $24.53▲ +12.83%▲ +14.73%$20.30 (−6.62%)
May 22, 2026
19w ago
3
NEUTRAL ★ 2/10
$22.79 $23.69▲ +3.95%▲ +5.37%$20.30 (−10.93%)
May 7, 2026
21w ago
8-K
MIXED ★ 6/10
$23.99 $20.66▼ −13.88%▼ −17.02%$20.30 (−15.38%)
May 4, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.24 $21.31▼ −12.09%▼ −17.73%$20.30 (−16.25%)
May 1, 2026
22w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.85 $21.31▼ −14.25%▼ −19.53%$20.30 (−18.31%)
Showing 10 of 15

US Market Status

Market Closed — Opens Mon (63h 54m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access